BPCR.L
Price:
$0.864
Market Cap:
$975.74M
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Industry
Asset Management
IPO Date
2017-03-27
Stock Exchange
LSE
Ticker
BPCR.L
According to BioPharma Credit PLC’s latest financial reports and current stock price. The company's current PE Ratio is 8.64. This represents a change of 129.03% compared to the average of 3.77 of the last 4 quarters.
The mean historical PE Ratio of BioPharma Credit PLC over the last ten years is 14.90. The current 8.64 PE Ratio has changed 5.70% with respect to the historical average. Over the past ten years (40 quarters), BPCR.L's PE Ratio was at its highest in in the June 2017 quarter at 28.84. The PE Ratio was at its lowest in in the June 2021 quarter at -0.26.
Average
14.90
Median
13.40
Minimum
7.16
Maximum
29.65
Discovering the peaks and valleys of BioPharma Credit PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 41.66%
Maximum Annual PE Ratio = 29.65
Minimum Annual Increase = -54.27%
Minimum Annual PE Ratio = 7.16
Year | PE Ratio | Change |
---|---|---|
2024 | 8.84 | -12.80% |
2023 | 10.14 | 41.66% |
2022 | 7.16 | -54.27% |
2021 | 15.65 | 1.97% |
2020 | 15.35 | 34.01% |
2019 | 11.46 | -45.34% |
2018 | 20.96 | -29.31% |
The current PE Ratio of BioPharma Credit PLC (BPCR.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.72
5-year avg
11.43
10-year avg
14.90
BioPharma Credit PLC’s PE Ratio is greater than JLEN Environmental Assets Group Limited (0), less than Sequoia Economic Infrastructure Income Fund Limited (9.29), less than CQS New City High Yield Fund Limited (9.24), less than HICL Infrastructure PLC (22.18), greater than Bluefield Solar Income Fund Limited (-46.60),
Company | PE Ratio | Market cap |
---|---|---|
0 | $611.61M | |
9.29 | $1.19B | |
9.24 | $303.49M | |
22.18 | $2.22B | |
-46.60 | $552.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioPharma Credit PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioPharma Credit PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioPharma Credit PLC's PE Ratio?
How is the PE Ratio calculated for BioPharma Credit PLC (BPCR.L)?
What is the highest PE Ratio for BioPharma Credit PLC (BPCR.L)?
What is the 3-year average PE Ratio for BioPharma Credit PLC (BPCR.L)?
What is the 5-year average PE Ratio for BioPharma Credit PLC (BPCR.L)?
How does the current PE Ratio for BioPharma Credit PLC (BPCR.L) compare to its historical average?